XYLOMETAZOLINE HYDROCHLORIDE

XYLOMETAZOLINE HYDROCHLORIDE was reported 568 times

XYLOMETAZOLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CENTRAL NERVOUS SYSTEM NEUROBLASTOMA 1 0.5000
1 PHOBIC POSTURAL VERTIGO 1 0.5000
2 ATOPIC COUGH 1 0.2500
3 CONGENITAL NASAL SEPTUM DEVIATION 2 0.2222
4 OPTIC DISC PIT 1 0.1429
5 APPENDICOLITH 40 0.1034
6 ANTACID THERAPY 10 0.0769
7 LENTICULOSTRIATAL VASCULOPATHY 2 0.0769
8 SLEEP DISORDER THERAPY 13 0.0657
9 EYELID CONTUSION 4 0.0597
10 ANALGESIC THERAPY 17 0.0530
11 LEUKAPHERESIS 1 0.0455
12 FEAR OF SURGERY 1 0.0435
13 PARAESTHESIA EAR 6 0.0408
14 DRUG THERAPY 13 0.0383
15 ANTICOAGULANT THERAPY 9 0.0317
16 CONGENITAL HIATUS HERNIA 7 0.0307
17 MACULAR TELANGIECTASIA 1 0.0303
18 GENITAL TRACT INFLAMMATION 6 0.0302
19 MALIGNANT MELANOMA STAGE 0 6 0.0287
20 REBOUND NASAL CONGESTION 4 0.0229
21 MUCOPOLYSACCHARIDOSIS II 1 0.0213
22 EYELID PTOSIS CONGENITAL 2 0.0211
23 ABNORMAL CORD INSERTION 1 0.0200
24 COLPOSCOPY 1 0.0179
25 CATHETER SITE GRANULOMA 1 0.0175
26 MASTOCYTOSIS 8 0.0169
27 TOXIC GOITRE 1 0.0164
28 ADRENAL ATROPHY 1 0.0161
29 PRIMARY STABBING HEADACHE 1 0.0141
30 HYPERPHOSPHATAEMIA 27 0.0125
31 BLOOD PHOSPHORUS INCREASED 34 0.0124
32 BACTEROIDES INFECTION 3 0.0115
33 VANISHING TWIN SYNDROME 1 0.0112
34 POSTMENOPAUSE 1 0.0086
35 COMPLICATED APPENDICITIS 1 0.0085
36 STENOTROPHOMONAS SEPSIS 1 0.0083
37 TRACHEOSTOMY INFECTION 1 0.0082
38 CARDIAC MONITORING 1 0.0082
39 ADENOIDITIS 1 0.0079
40 OPTIC NERVE CUPPING 1 0.0079
41 GASTROINTESTINAL STOMA OUTPUT DECREASED 1 0.0071
42 GENITAL BURNING SENSATION 6 0.0069
43 PLACENTAL TRANSFUSION SYNDROME 1 0.0069
44 HYPOBARISM 1 0.0067
45 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 6 0.0065
46 BLOOD INSULIN DECREASED 1 0.0065
47 BACTERIAL TRANSLOCATION 2 0.0063
48 INTESTINAL STRANGULATION 1 0.0062
49 BLOOD IMMUNOGLOBULIN G ABNORMAL 1 0.0060
50 PYLORIC STENOSIS 5 0.0059
51 PELVIC FLOOR MUSCLE WEAKNESS 1 0.0058
52 TONGUE FUNGAL INFECTION 1 0.0058
53 NASAL TURBINATE HYPERTROPHY 2 0.0053
54 AGITATION NEONATAL 5 0.0052
55 STREPTOCOCCAL URINARY TRACT INFECTION 1 0.0052
56 VITAMIN B12 INCREASED 4 0.0050
57 WEGENER'S GRANULOMATOSIS 1 0.0050
58 PREMENSTRUAL DYSPHORIC DISORDER 1 0.0049
59 LICE INFESTATION 1 0.0048
60 PARENTERAL NUTRITION 1 0.0043
61 BLOOD URIC ACID INCREASED 25 0.0043
62 APPENDICITIS 40 0.0043
63 IRON DEFICIENCY 19 0.0042
64 IVTH NERVE PARALYSIS 1 0.0042
65 CREST SYNDROME 1 0.0042
66 JEJUNAL PERFORATION 1 0.0041
67 BREAST DISORDER FEMALE 1 0.0039
68 THUNDERCLAP HEADACHE 1 0.0038
69 TOTAL LUNG CAPACITY DECREASED 6 0.0038
70 SHOULDER FRACTURE 6 0.0037
71 CIRCADIAN RHYTHM SLEEP DISORDER 3 0.0036
72 MYASTHENIA GRAVIS 29 0.0036
73 HYPOPHOSPHATAEMIA 26 0.0035
74 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
75 NASAL MUCOSAL DISORDER 2 0.0034
76 VENTRICULAR FIBRILLATION 37 0.0033
77 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
78 NEONATAL DISORDER 5 0.0032
79 TUMOUR PERFORATION 1 0.0031
80 BOREDOM 1 0.0029
81 PTERYGIUM 1 0.0029
82 TRANCE 1 0.0027
83 KERATOCONJUNCTIVITIS SICCA 1 0.0027
84 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
85 CARDIOGENIC SHOCK 38 0.0026
86 NSAID EXACERBATED RESPIRATORY DISEASE 1 0.0026
87 IMMUNE-MEDIATED ARTHRITIS 1 0.0026
88 AORTIC STENOSIS 9 0.0026
89 PRURITUS GENITAL 6 0.0025
90 GESTATIONAL DIABETES 12 0.0025
91 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
92 PANCREATIC ATROPHY 1 0.0023
93 CERVICITIS 1 0.0022
94 CYSTITIS NONINFECTIVE 3 0.0022
95 ALLERGY TO PLANTS 1 0.0022
96 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
97 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
98 HELPLESSNESS 1 0.0021
99 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
100 PULMONARY PAIN 6 0.0021
101 CEREBRAL ARTERY STENOSIS 1 0.0020
102 URINARY TRACT PAIN 1 0.0020
103 EYELID PAIN 4 0.0020
104 FEMALE STERILISATION 1 0.0019
105 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
106 PLASMAPHERESIS 1 0.0019
107 PERIORBITAL CELLULITIS 1 0.0019
108 TROPONIN INCREASED 14 0.0018
109 MORNING SICKNESS 1 0.0018
110 MILK ALLERGY 1 0.0018
111 PLEURITIC PAIN 5 0.0018
112 CARDIOSPASM 1 0.0018
113 CATHETER SITE INFLAMMATION 1 0.0018
114 RESPIRATORY SYMPTOM 5 0.0018
115 RADIATION NECROSIS 1 0.0017
116 OPHTHALMIC HERPES SIMPLEX 1 0.0017
117 STREPTOCOCCAL SEPSIS 2 0.0017
118 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
119 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
120 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
121 DEVICE INFUSION ISSUE 4 0.0016
122 BACTERIAL INFECTION 30 0.0016
123 INFUSION SITE PRURITUS 5 0.0016
124 ASCITES 45 0.0015
125 LUNG OPACITY 4 0.0015
126 BRONCHIECTASIS 10 0.0015
127 MULTIPLE ORGAN DYSFUNCTION SYNDROME 41 0.0014
128 THYROXINE INCREASED 1 0.0014
129 BORDERLINE PERSONALITY DISORDER 1 0.0014
130 CARDIAC SEPTAL DEFECT 1 0.0014
131 INFUSION SITE BRUISING 3 0.0014
132 DISSOCIATIVE DISORDER 1 0.0014
133 GASTROINTESTINAL SCARRING 1 0.0014
134 BLOOD CALCIUM INCREASED 12 0.0014
135 INDIFFERENCE 1 0.0013
136 ENTEROVESICAL FISTULA 1 0.0013
137 BLOOD PRESSURE IMMEASURABLE 2 0.0013
138 PNEUMONIA PSEUDOMONAL 2 0.0013
139 ALLERGIC COUGH 1 0.0013
140 MEAN CELL VOLUME DECREASED 2 0.0013
141 GASTROSTOMY 2 0.0013
142 NASAL DRYNESS 8 0.0013
143 NEURALGIA 31 0.0013
144 GOUTY ARTHRITIS 1 0.0013
145 HEAT EXHAUSTION 1 0.0012
146 RESPIRATORY DISORDER NEONATAL 2 0.0012
147 INFUSION SITE HAEMORRHAGE 4 0.0012
148 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
149 COVID-19 IMMUNISATION 1 0.0012
150 SEROUS RETINAL DETACHMENT 1 0.0012
151 TWIN PREGNANCY 1 0.0012
152 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
153 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
154 TONSILLITIS 6 0.0011
155 VASOCONSTRICTION 1 0.0011
156 JAW OPERATION 1 0.0011
157 CATARRH 1 0.0011
158 MUCOSAL EROSION 1 0.0011
159 ESSENTIAL HYPERTENSION 2 0.0011
160 GASTRIC OPERATION 1 0.0011
161 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
162 HYPERLIPIDAEMIA 13 0.0011
163 PSYCHOGENIC SEIZURE 1 0.0011
164 NASAL OBSTRUCTION 2 0.0011
165 CHRONIC SINUSITIS 4 0.0011
166 COLON NEOPLASM 1 0.0010
167 NASAL SEPTUM DEVIATION 2 0.0010
168 BREATH SOUNDS ABNORMAL 5 0.0010
169 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 2 0.0010
170 MUCOSAL ULCERATION 1 0.0010
171 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
172 STOMA COMPLICATION 1 0.0010
173 INFUSION SITE DISCOMFORT 1 0.0010
174 OEDEMA MUCOSAL 1 0.0010
175 TUMOUR NECROSIS 1 0.0009
176 NASAL INFLAMMATION 1 0.0009
177 ALLERGY TO ANIMAL 1 0.0009
178 SOMATIC SYMPTOM DISORDER 1 0.0009
179 INFUSION SITE MASS 1 0.0009
180 TINEA INFECTION 1 0.0009
181 AORTIC DILATATION 1 0.0009
182 DEMENTIA WITH LEWY BODIES 1 0.0009
183 ESSENTIAL TREMOR 1 0.0009
184 KLEBSIELLA SEPSIS 1 0.0009
185 METABOLIC SURGERY 1 0.0009
186 WOUND COMPLICATION 3 0.0009
187 MACROCYTOSIS 1 0.0009
188 PAROTITIS 1 0.0009
189 OSTEOCHONDROSIS 1 0.0009
190 SPLENECTOMY 1 0.0009
191 GOUT 15 0.0008
192 BLEEDING TIME PROLONGED 1 0.0008
193 DERMATITIS ACNEIFORM 5 0.0008
194 ULCER 13 0.0008
195 INFUSION SITE WARMTH 1 0.0008
196 HAEMATOCRIT ABNORMAL 1 0.0008
197 PHARYNGEAL HAEMORRHAGE 1 0.0008
198 GLUCOSE URINE PRESENT 1 0.0008
199 BLOOD TEST ABNORMAL 11 0.0008
200 BLOOD BILIRUBIN ABNORMAL 1 0.0008
201 DACRYOSTENOSIS ACQUIRED 1 0.0008
202 REHABILITATION THERAPY 3 0.0008
203 BILIARY OBSTRUCTION 1 0.0008
204 HYPONATRAEMIA 43 0.0008
205 PHARYNGEAL ULCERATION 1 0.0008
206 BLOOD POTASSIUM ABNORMAL 2 0.0007
207 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
208 SIALOADENITIS 1 0.0007
209 INFUSION SITE RASH 1 0.0007
210 STEVENS-JOHNSON SYNDROME 16 0.0007
211 ATRIAL SEPTAL DEFECT 6 0.0007
212 THERAPEUTIC PROCEDURE 1 0.0007
213 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
214 PROTHROMBIN TIME SHORTENED 1 0.0007
215 MAST CELL ACTIVATION SYNDROME 1 0.0007
216 END STAGE RENAL DISEASE 13 0.0007
217 POST HERPETIC NEURALGIA 1 0.0007
218 BILIARY COLIC 2 0.0007
219 NEGATIVE THOUGHTS 2 0.0007
220 MYASTHENIA GRAVIS CRISIS 1 0.0007
221 VIOLENCE-RELATED SYMPTOM 1 0.0006
222 SUBSTANCE USE 1 0.0006
223 PRE-EXISTING CONDITION IMPROVED 4 0.0006
224 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
225 OPHTHALMOPLEGIA 1 0.0006
226 HYPERCHOLESTEROLAEMIA 6 0.0006
227 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
228 MICTURITION URGENCY 7 0.0006
229 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
230 SYSTEMIC INFECTION 1 0.0006
231 ARTHROPOD STING 1 0.0006
232 TROPONIN I INCREASED 1 0.0006
233 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
234 GASTRIC DILATATION 1 0.0006
235 VEIN RUPTURE 1 0.0006
236 SUBARACHNOID HAEMORRHAGE 6 0.0006
237 EXPOSURE TO SARS-COV-2 1 0.0006
238 GLIOBLASTOMA 1 0.0006
239 CERVICAL SPINAL STENOSIS 1 0.0006
240 ACUTE SINUSITIS 1 0.0006
241 VERTIGO POSITIONAL 1 0.0006
242 EMOTIONAL POVERTY 1 0.0006
243 HERNIA 11 0.0006
244 ILEAL STENOSIS 1 0.0006
245 HAEMORRHAGIC DIATHESIS 2 0.0006
246 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
247 BLOOD CHOLESTEROL INCREASED 26 0.0006
248 VISUAL FIELD DEFECT 4 0.0006
249 DEVICE ALARM ISSUE 1 0.0006
250 ASPIRATION 6 0.0005
251 CONTRAST MEDIA ALLERGY 1 0.0005
252 IRON DEFICIENCY ANAEMIA 5 0.0005
253 DENTAL CARE 1 0.0005
254 LYMPH NODE PAIN 1 0.0005
255 NARCOLEPSY 1 0.0005
256 SEPSIS 59 0.0005
257 JAUNDICE NEONATAL 1 0.0005
258 GASTRIC ULCER 10 0.0005
259 VENTRICULAR SEPTAL DEFECT 3 0.0005
260 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
261 FOOD ALLERGY 4 0.0005
262 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
263 TRAUMATIC LUNG INJURY 1 0.0005
264 ABDOMINAL DISTENSION 54 0.0005
265 OCULAR HYPERTENSION 1 0.0005
266 ALCOHOL INTERACTION 1 0.0005
267 HYPOGEUSIA 1 0.0005
268 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
269 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
270 DEVICE RELATED SEPSIS 1 0.0005
271 IMMUNE-MEDIATED HEPATITIS 1 0.0005
272 MUSCLE SPASTICITY 6 0.0005
273 POLYCYTHAEMIA 1 0.0005
274 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
275 BLEPHAROSPASM 3 0.0005
276 EYE CONTUSION 1 0.0005
277 FULL BLOOD COUNT ABNORMAL 5 0.0005
278 PHARYNGEAL ERYTHEMA 1 0.0005
279 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
280 ANAEMIA MACROCYTIC 1 0.0005
281 JOINT INJURY 10 0.0005
282 LIVER FUNCTION TEST INCREASED 10 0.0005
283 INFUSION SITE PAIN 6 0.0005
284 DEREALISATION 1 0.0005
285 CATHETERISATION CARDIAC 2 0.0005
286 GASTROINTESTINAL ULCER 1 0.0005
287 POST-TRAUMATIC STRESS DISORDER 3 0.0004
288 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
289 DRY MOUTH 36 0.0004
290 GASTRIC POLYPS 1 0.0004
291 DERMATITIS CONTACT 5 0.0004
292 LICHEN PLANUS 1 0.0004
293 ARTHRITIS INFECTIVE 2 0.0004
294 NECK SURGERY 1 0.0004
295 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
296 SINUS PAIN 1 0.0004
297 ESCHERICHIA BACTERAEMIA 1 0.0004
298 URINARY HESITATION 1 0.0004
299 VARICELLA 1 0.0004
300 WRONG DOSE 1 0.0004
301 DRUG INTOLERANCE 39 0.0004
302 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
303 GASTROINTESTINAL TUBE INSERTION 1 0.0004
304 VENOOCCLUSIVE DISEASE 1 0.0004
305 METASTASES TO PERITONEUM 1 0.0004
306 DYSPHORIA 2 0.0004
307 HAEMORRHAGE URINARY TRACT 1 0.0004
308 ABNORMAL UTERINE BLEEDING 1 0.0004
309 PARTIAL SEIZURES 2 0.0004
310 DIABETES MELLITUS 29 0.0004
311 NASAL DISCOMFORT 3 0.0004
312 NASAL DISORDER 1 0.0004
313 ALCOHOL ABUSE 1 0.0004
314 PHOTOPHOBIA 7 0.0004
315 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
316 SLEEP DISORDER 26 0.0004
317 RHINALGIA 1 0.0004
318 ERUCTATION 7 0.0004
319 PROCTITIS 1 0.0004
320 SEASONAL ALLERGY 5 0.0004
321 OXYGEN SATURATION ABNORMAL 1 0.0004
322 THROMBOSIS 28 0.0003
323 RETINAL VEIN OCCLUSION 1 0.0003
324 PHARYNGEAL DISORDER 1 0.0003
325 PARAPLEGIA 1 0.0003
326 DYSPNOEA EXERTIONAL 13 0.0003
327 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
328 SKIN WARM 2 0.0003
329 DEVICE POWER SOURCE ISSUE 1 0.0003
330 THORACIC VERTEBRAL FRACTURE 1 0.0003
331 DRUG WITHDRAWAL SYNDROME NEONATAL 5 0.0003
332 INFUSION SITE REACTION 1 0.0003
333 ATYPICAL PNEUMONIA 1 0.0003
334 ANAL INCONTINENCE 3 0.0003
335 CEREBROVASCULAR DISORDER 1 0.0003
336 INTENTIONAL PRODUCT MISUSE 29 0.0003
337 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
338 KERATITIS 1 0.0003
339 CHEST X-RAY ABNORMAL 1 0.0003
340 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
341 GLAUCOMA 6 0.0003
342 VENTRICULAR HYPOKINESIA 1 0.0003
343 SKIN EROSION 1 0.0003
344 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
345 BACTERIAL SEPSIS 1 0.0003
346 PULMONARY CONGESTION 4 0.0003
347 SUSPECTED COVID-19 1 0.0003
348 SINUS DISORDER 6 0.0003
349 OTITIS MEDIA 1 0.0003
350 APPETITE DISORDER 2 0.0003
351 EXPIRED DEVICE USED 1 0.0003
352 ANXIETY DISORDER 1 0.0003
353 TONGUE ULCERATION 1 0.0003
354 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
355 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
356 SINUSITIS 30 0.0003
357 HEPATIC FIBROSIS 1 0.0003
358 BLOOD CREATININE ABNORMAL 1 0.0003
359 TACHYPHRENIA 1 0.0003
360 POLYMENORRHOEA 1 0.0003
361 HYPOPNOEA 1 0.0003
362 CAROTID ARTERY STENOSIS 1 0.0003
363 PULMONARY EMBOLISM 27 0.0003
364 NEUTROPENIC SEPSIS 2 0.0003
365 IMPAIRED QUALITY OF LIFE 4 0.0003
366 SWELLING 26 0.0003
367 MYELODYSPLASTIC SYNDROME 4 0.0003
368 MONOCYTE COUNT INCREASED 1 0.0003
369 RESTLESS LEGS SYNDROME 5 0.0003
370 FOOD INTOLERANCE 1 0.0003
371 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
372 TENDON INJURY 1 0.0003
373 NEURODERMATITIS 1 0.0003
374 DEAFNESS 7 0.0003
375 MUCOSAL INFLAMMATION 7 0.0003
376 LACRIMATION INCREASED 8 0.0003
377 SNORING 1 0.0003
378 GINGIVAL DISORDER 1 0.0003
379 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
380 RHINOVIRUS INFECTION 1 0.0003
381 SWOLLEN TONGUE 8 0.0003
382 MULTIPLE ALLERGIES 2 0.0003
383 VENOUS THROMBOSIS 1 0.0003
384 AFFECTIVE DISORDER 2 0.0003
385 BLOOD IRON DECREASED 3 0.0003
386 DISEASE RECURRENCE 12 0.0003
387 BLOOD PRESSURE ABNORMAL 5 0.0003
388 COVID-19 44 0.0003
389 SENSORY DISTURBANCE 4 0.0002
390 RHINITIS 2 0.0002
391 ARTHRITIS BACTERIAL 1 0.0002
392 OSTEOPOROSIS 10 0.0002
393 CONSTIPATION 53 0.0002
394 VENTRICULAR TACHYCARDIA 4 0.0002
395 EXPOSURE DURING PREGNANCY 15 0.0002
396 SECRETION DISCHARGE 3 0.0002
397 SOMNOLENCE 48 0.0002
398 ONYCHOMADESIS 1 0.0002
399 SLEEP TERROR 1 0.0002
400 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
401 INFUSION SITE ERYTHEMA 2 0.0002
402 CANDIDA INFECTION 4 0.0002
403 MUSCLE FATIGUE 1 0.0002
404 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
405 INTERVERTEBRAL DISC DISORDER 1 0.0002
406 SHOULDER OPERATION 1 0.0002
407 MUSCLE STRAIN 2 0.0002
408 URINE OUTPUT DECREASED 2 0.0002
409 MELAENA 5 0.0002
410 LIMB DISCOMFORT 7 0.0002
411 EAR INFECTION 6 0.0002
412 TRANSAMINASES INCREASED 5 0.0002
413 FACIAL PAIN 2 0.0002
414 MENINGITIS ASEPTIC 1 0.0002
415 URINARY TRACT DISORDER 1 0.0002
416 VASCULAR DEVICE INFECTION 1 0.0002
417 URINE ABNORMALITY 1 0.0002
418 PANIC ATTACK 8 0.0002
419 ABDOMINAL HERNIA 1 0.0002
420 IMMUNE THROMBOCYTOPENIA 1 0.0002
421 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
422 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
423 CONJUNCTIVITIS 4 0.0002
424 ANAEMIA 41 0.0002
425 THINKING ABNORMAL 4 0.0002
426 ROSACEA 1 0.0002
427 FEELING OF DESPAIR 1 0.0002
428 UMBILICAL HERNIA 1 0.0002
429 YELLOW SKIN 1 0.0002
430 SKIN ABRASION 1 0.0002
431 DRUG DEPENDENCE 34 0.0002
432 PRE-ECLAMPSIA 1 0.0002
433 HYPERSOMNIA 6 0.0002
434 VULVOVAGINAL PAIN 1 0.0002
435 MENTAL DISORDER 9 0.0002
436 BODY TEMPERATURE DECREASED 2 0.0002
437 OVARIAN CYST 2 0.0002
438 BLOOD CREATININE INCREASED 13 0.0002
439 CORONARY ARTERY DISEASE 6 0.0002
440 ABDOMINAL PAIN 46 0.0002
441 CORONARY ARTERIAL STENT INSERTION 1 0.0002
442 CARDIOVASCULAR DISORDER 5 0.0002
443 PETIT MAL EPILEPSY 1 0.0002
444 EAR DISCOMFORT 2 0.0002
445 EMOTIONAL DISORDER 6 0.0002
446 PERIPHERAL VASCULAR DISORDER 1 0.0002
447 ANKLE FRACTURE 3 0.0002
448 PERIORBITAL OEDEMA 1 0.0002
449 TENDERNESS 2 0.0002
450 PETECHIAE 2 0.0002
451 FOOD POISONING 1 0.0002
452 OVERWEIGHT 1 0.0002
453 BRUXISM 1 0.0002
454 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
455 FAECALOMA 1 0.0002
456 GASTROINTESTINAL PAIN 2 0.0002
457 CHOKING SENSATION 1 0.0002
458 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
459 DRUG LEVEL INCREASED 3 0.0002
460 INTERMENSTRUAL BLEEDING 1 0.0002
461 ORAL PAIN 4 0.0002
462 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
463 REBOUND EFFECT 2 0.0002
464 PERIORBITAL SWELLING 1 0.0002
465 PERONEAL NERVE PALSY 1 0.0002
466 NEUTROPHILIA 1 0.0002
467 CHOLECYSTECTOMY 2 0.0002
468 CONDITION AGGRAVATED 53 0.0002
469 HERPES VIRUS INFECTION 1 0.0002
470 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
471 HYPERVENTILATION 1 0.0002
472 RALES 1 0.0002
473 CAESAREAN SECTION 2 0.0002
474 NEEDLE ISSUE 5 0.0002
475 MUSCULOSKELETAL STIFFNESS 15 0.0002
476 HYPOVOLAEMIA 1 0.0002
477 DECREASED INTEREST 1 0.0002
478 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
479 ATAXIA 2 0.0002
480 GALLBLADDER DISORDER 3 0.0002
481 ODYNOPHAGIA 1 0.0002
482 SYMPTOM RECURRENCE 1 0.0002
483 GASTROENTERITIS VIRAL 3 0.0002
484 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
485 PLATELET COUNT ABNORMAL 1 0.0002
486 INJECTION SITE VESICLES 1 0.0002
487 ILLNESS 17 0.0002
488 PLEURAL EFFUSION 10 0.0002
489 MENISCUS INJURY 1 0.0002
490 BRONCHITIS 12 0.0002
491 SCOLIOSIS 1 0.0002
492 INFUSION SITE EXTRAVASATION 1 0.0002
493 SWELLING OF EYELID 1 0.0002
494 INFUSION SITE SWELLING 1 0.0002
495 FOOT FRACTURE 3 0.0002
496 LIVER DISORDER 7 0.0002
497 SLEEP APNOEA SYNDROME 3 0.0002
498 FOREIGN BODY SENSATION IN EYES 1 0.0002
499 ROTATOR CUFF SYNDROME 2 0.0002
500 HAEMOGLOBIN ABNORMAL 1 0.0002
501 RHINORRHOEA 10 0.0002
502 EAR PAIN 3 0.0002
503 HAEMORRHOIDS 3 0.0002
504 ORAL HERPES 3 0.0002
505 PLATELET COUNT INCREASED 2 0.0002
506 NASAL CONGESTION 9 0.0002
507 SOMNAMBULISM 1 0.0002
508 MALIGNANT MELANOMA 2 0.0001
509 INTENTIONAL SELF-INJURY 3 0.0001
510 OCULAR HYPERAEMIA 7 0.0001
511 IMPAIRED GASTRIC EMPTYING 2 0.0001
512 ECCHYMOSIS 1 0.0001
513 RESPIRATION ABNORMAL 1 0.0001
514 JOINT EFFUSION 1 0.0001
515 FORMICATION 1 0.0001
516 EXTRASYSTOLES 1 0.0001
517 PAPULE 1 0.0001
518 PAIN IN JAW 4 0.0001
519 INTENTIONAL DOSE OMISSION 4 0.0001
520 PANIC REACTION 1 0.0001
521 LIVER FUNCTION TEST ABNORMAL 4 0.0001
522 RASH PUSTULAR 1 0.0001
523 INTENTIONAL UNDERDOSE 1 0.0001
524 MAJOR DEPRESSION 1 0.0001
525 ORAL DISORDER 1 0.0001
526 MOUTH HAEMORRHAGE 1 0.0001
527 WHEEZING 8 0.0001
528 FEELING DRUNK 1 0.0001
529 HEPATIC FUNCTION ABNORMAL 5 0.0001
530 RESPIRATORY DISORDER 4 0.0001
531 BREAST TENDERNESS 1 0.0001
532 ASTHMA 15 0.0001
533 PAROSMIA 1 0.0001
534 BOWEL MOVEMENT IRREGULARITY 1 0.0001
535 LIPASE INCREASED 1 0.0001
536 OROPHARYNGEAL PAIN 12 0.0001
537 APHTHOUS ULCER 1 0.0001
538 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
539 OBESITY 2 0.0001
540 NASOPHARYNGITIS 23 0.0001
541 FRUSTRATION TOLERANCE DECREASED 1 0.0001
542 MUSCLE DISORDER 1 0.0001
543 SUBSTANCE ABUSE 1 0.0001
544 ASPHYXIA 1 0.0001
545 LUNG DISORDER 6 0.0001
546 ABNORMAL FAECES 1 0.0001
547 CHOLELITHIASIS 4 0.0001
548 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
549 EMBOLISM 1 0.0001
550 COAGULOPATHY 2 0.0001
551 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
552 VOMITING 55 0.0001
553 VITAMIN D DECREASED 1 0.0001
554 PSEUDOMONAS INFECTION 1 0.0001
555 INFLUENZA 13 0.0001
556 CARDIAC MURMUR 1 0.0001
557 HYSTERECTOMY 1 0.0001
558 PYELONEPHRITIS 1 0.0001
559 MIGRAINE 11 0.0001
560 RESPIRATORY TRACT INFECTION 3 0.0001
561 SEDATION 3 0.0001
562 SPINAL OSTEOARTHRITIS 1 0.0001
563 GRIP STRENGTH DECREASED 1 0.0001
564 DEPRESSED MOOD 6 0.0001
565 LUNG INFILTRATION 1 0.0001
566 HEAD DISCOMFORT 2 0.0001
567 RESPIRATORY RATE INCREASED 1 0.0001
568 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
569 BLOOD BILIRUBIN INCREASED 3 0.0001
570 OPTIC NEURITIS 1 0.0001
571 MOOD ALTERED 3 0.0001
572 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
573 BRAIN NEOPLASM 1 0.0001
574 INCREASED TENDENCY TO BRUISE 1 0.0001
575 ANAPHYLACTIC REACTION 6 0.0001
576 BLOOD GLUCOSE ABNORMAL 2 0.0001
577 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
578 PERSONALITY CHANGE 1 0.0001
579 AGRANULOCYTOSIS 2 0.0001
580 HAEMOPTYSIS 3 0.0001
581 THROMBOCYTOPENIA 12 0.0001
582 EYE PAIN 6 0.0001
583 BLOOD SODIUM DECREASED 2 0.0001
584 SPUTUM DISCOLOURED 1 0.0001
585 PRESCRIBED OVERDOSE 2 0.0001
586 SKIN FISSURES 2 0.0001
587 KIDNEY INFECTION 2 0.0001
588 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
589 KNEE OPERATION 1 0.0001
590 DISORIENTATION 4 0.0001
591 HAEMATOCRIT DECREASED 2 0.0001
592 BLADDER DISORDER 1 0.0001
593 COMPLICATION OF DEVICE INSERTION 2 0.0001
594 GASTROINTESTINAL DISORDER 9 0.0001
595 SALIVARY HYPERSECRETION 1 0.0001
596 CYTOKINE RELEASE SYNDROME 2 0.0001
597 HYPERTENSION 21 0.0001
598 TASTE DISORDER 2 0.0001
599 SUICIDAL IDEATION 9 0.0001
600 TOOTH ABSCESS 1 0.0001
601 SLUGGISHNESS 1 0.0001
602 NEUTROPHIL COUNT INCREASED 1 0.0001
603 EUPHORIC MOOD 1 0.0001
604 INITIAL INSOMNIA 1 0.0001
605 DYSPNOEA 55 0.0001
606 TEMPERATURE INTOLERANCE 1 0.0001
607 EYE DISCHARGE 1 0.0001
608 INTENTIONAL DRUG MISUSE 2 0.0001
609 MOUTH ULCERATION 2 0.0001
610 JOINT DISLOCATION 1 0.0001
611 RENAL PAIN 1 0.0001
612 METABOLIC ACIDOSIS 3 0.0001
613 RETCHING 2 0.0001
614 MOVEMENT DISORDER 3 0.0001
615 IRRITABLE BOWEL SYNDROME 2 0.0001
616 HEREDITARY ANGIOEDEMA 1 0.0001
617 NIGHT SWEATS 3 0.0001
618 PHARYNGITIS STREPTOCOCCAL 1 0.0001
619 NAUSEA 73 0.0001
620 OEDEMA 5 0.0001
621 BIPOLAR DISORDER 1 0.0001
622 SKIN LACERATION 1 0.0001
623 BACK INJURY 1 0.0001
624 ALOPECIA 18 0.0001
625 OESOPHAGITIS 1 0.0001
626 DYSPEPSIA 9 0.0001
627 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
628 DENTAL CARIES 1 0.0001
629 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
630 EXPIRED PRODUCT ADMINISTERED 3 0.0001
631 OEDEMA PERIPHERAL 11 0.0001
632 VIRAL INFECTION 3 0.0001
633 SKIN DISORDER 3 0.0001
634 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
635 MALNUTRITION 1 0.0001
636 SNEEZING 2 0.0001
637 THROAT IRRITATION 4 0.0001
638 COUGH 25 0.0001
639 INTESTINAL PERFORATION 1 0.0001
640 BLOOD CALCIUM DECREASED 1 0.0001
641 GAIT DISTURBANCE 17 0.0001
642 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
643 FLATULENCE 5 0.0001
644 DEPRESSION 20 0.0001
645 HERPES ZOSTER 5 0.0001
646 GASTRIC HAEMORRHAGE 1 0.0001
647 NIGHTMARE 3 0.0001
648 EYELID OEDEMA 1 0.0001
649 HEART RATE DECREASED 3 0.0001
650 SPLENOMEGALY 1 0.0001
651 HYPOXIA 3 0.0001
652 LYMPHADENOPATHY 3 0.0001
653 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
654 MULTIPLE SCLEROSIS 4 0.0001
655 MUSCLE RIGIDITY 1 0.0001
656 POLYNEUROPATHY 1 0.0001
657 WRIST FRACTURE 1 0.0001
658 IRRITABILITY 5 0.0001
659 WEIGHT DECREASED 23 0.0001
660 VERTIGO 5 0.0001
661 RESTLESSNESS 3 0.0001
662 RESPIRATORY DEPRESSION 1 0.0001
663 LIVER INJURY 2 0.0001
664 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
665 SPINAL OPERATION 1 0.0001
666 INJECTION SITE EXTRAVASATION 1 0.0001
667 NEUTROPENIA 11 0.0001
668 VISUAL IMPAIRMENT 10 0.0001
669 CYST 1 0.0001
670 HOT FLUSH 6 0.0001
671 INTESTINAL OBSTRUCTION 3 0.0001
672 MUSCULAR WEAKNESS 9 0.0001
673 BRAIN OEDEMA 1 0.0001
674 INJECTION SITE IRRITATION 1 0.0001
675 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
676 INTRAOCULAR PRESSURE INCREASED 1 0.0001
677 CHEST DISCOMFORT 8 0.0001
678 DRUG RESISTANCE 2 0.0001
679 ABDOMINAL DISCOMFORT 13 0.0001
680 NERVOUSNESS 4 0.0001
681 ARTHRITIS 6 0.0001
682 ANHEDONIA 2 0.0001
683 ORAL CANDIDIASIS 1 0.0001
684 DERMATITIS ATOPIC 4 0.0001
685 TOOTH INFECTION 1 0.0001
686 SARS-COV-2 TEST POSITIVE 1 0.0001
687 ADVERSE REACTION 1 0.0001
688 SINUS CONGESTION 1 0.0001
689 AKATHISIA 1 0.0001
690 GINGIVAL BLEEDING 1 0.0001
691 PERIPHERAL COLDNESS 1 0.0001
692 HAEMATOCHEZIA 4 0.0001
693 PROCEDURAL PAIN 2 0.0001
694 POLLAKIURIA 3 0.0001
695 HYPOMAGNESAEMIA 1 0.0001
696 ASTHENIA 27 0.0001
697 APHONIA 1 0.0001
698 WOUND 2 0.0001
699 PRODUCT DOSE OMISSION ISSUE 21 0.0001
700 CARPAL TUNNEL SYNDROME 1 0.0001
701 BLISTER 4 0.0001
702 DEVICE OCCLUSION 1 0.0001
703 LYMPHOPENIA 1 0.0001
704 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
705 URINARY TRACT INFECTION 12 0.0001
706 RED BLOOD CELL COUNT DECREASED 2 0.0001
707 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
708 PARAESTHESIA ORAL 1 0.0001
709 ANOSMIA 1 0.0001
710 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
711 FLUSHING 7 0.0001
712 HEADACHE 43 0.0001
713 APATHY 1 0.0001
714 GASTROENTERITIS 1 0.0001
715 FATIGUE 53 0.0001
716 SKIN HAEMORRHAGE 1 0.0001
717 PULMONARY MASS 1 0.0001
718 COLON CANCER 1 0.0001
719 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
720 PYREXIA 23 0.0001
721 JOINT SWELLING 8 0.0001
722 OSTEOPENIA 1 0.0001
723 CHRONIC KIDNEY DISEASE 5 0.0001
724 SKIN IRRITATION 3 0.0001
725 NEPHROLITHIASIS 3 0.0001
726 INSURANCE ISSUE 1 0.0001
727 TINNITUS 3 0.0001
728 SKIN DISCOLOURATION 3 0.0001
729 INJECTION SITE RASH 2 0.0001
730 PNEUMONIA 21 0.0001
731 CHEST PAIN 12 0.0001
732 MUSCULOSKELETAL CHEST PAIN 1 0.0001
733 DELUSION 1 0.0001
734 DIZZINESS 32 0.0001
735 THERAPY PARTIAL RESPONDER 1 0.0001
736 BASAL CELL CARCINOMA 1 0.0001
737 BRAIN FOG 1 0.0001
738 CYANOSIS 1 0.0001
739 DYSPHAGIA 6 0.0001
740 PNEUMOTHORAX 1 0.0001
741 PRODUCTIVE COUGH 3 0.0001
742 PREMATURE DELIVERY 1 0.0001
743 SCIATICA 1 0.0001
744 INTENTIONAL OVERDOSE 4 0.0001
745 CONTUSION 6 0.0001
746 INTERSTITIAL LUNG DISEASE 3 0.0001
747 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
748 ARTHRALGIA 25 0.0001
749 INSOMNIA 16 0.0001
750 LIP SWELLING 2 0.0001
751 MUSCLE SPASMS 11 0.0001
752 URINARY RETENTION 2 0.0001
753 GAIT INABILITY 2 0.0001
754 BLOOD UREA INCREASED 1 0.0001
755 ANGER 2 0.0001
756 HEMIPARESIS 1 0.0001
757 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
758 ABDOMINAL PAIN UPPER 12 0.0001
759 MUSCULOSKELETAL DISCOMFORT 1 0.0001
760 MULTI-ORGAN FAILURE 1 0.0001
761 ECZEMA 3 0.0001
762 PARAESTHESIA 9 0.0001
763 COLD SWEAT 1 0.0001
764 LYMPHOCYTE COUNT DECREASED 1 0.0001
765 DRUG ERUPTION 1 0.0001
766 ANXIETY 16 0.0001
767 ISCHAEMIC STROKE 1 0.0001
768 DECREASED APPETITE 13 0.0001
769 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
770 COMPLICATION OF DEVICE REMOVAL 1 0.0001
771 INFECTION 8 0.0001
772 C-REACTIVE PROTEIN INCREASED 2 0.0001
773 HYPERGLYCAEMIA 2 0.0001
774 OFF LABEL USE 48 0.0001
775 AGITATION 4 0.0001
776 TREMOR 9 0.0001
777 HYPERSENSITIVITY 10 0.0001
778 HEPATIC STEATOSIS 1 0.0001
779 NECK PAIN 3 0.0001
780 HALLUCINATION 4 0.0001
781 RHEUMATOID ARTHRITIS 6 0.0001
782 FRACTURE 1 0.0001
783 COLITIS 2 0.0001
784 PROTEINURIA 1 0.0001
785 NEUROPATHY PERIPHERAL 5 0.0001
786 FEELING JITTERY 1 0.0001
787 DRY SKIN 7 0.0001
788 INJECTION SITE SWELLING 4 0.0001
789 PULMONARY FIBROSIS 1 0.0001
790 BACK PAIN 12 0.0001
791 ATRIAL FIBRILLATION 5 0.0001
792 CHOKING 1 0.0001
793 SURGERY 3 0.0001
794 DIARRHOEA 33 0.0001
795 FALL 17 0.0001
796 DISABILITY 1 0.0001
797 ABNORMAL BEHAVIOUR 2 0.0001
798 CATARACT 3 0.0001
799 ABORTION SPONTANEOUS 2 0.0000
800 SPINAL FRACTURE 1 0.0000
801 PRODUCT PHYSICAL ISSUE 1 0.0000
802 SUICIDE ATTEMPT 3 0.0000
803 WEIGHT INCREASED 11 0.0000
804 TOOTH LOSS 1 0.0000
805 RASH 21 0.0000
806 PULMONARY HYPERTENSION 1 0.0000
807 OSTEOARTHRITIS 2 0.0000
808 EATING DISORDER 1 0.0000
809 PRURITUS 18 0.0000
810 LOSS OF CONSCIOUSNESS 6 0.0000
811 POOR QUALITY SLEEP 1 0.0000
812 BALANCE DISORDER 4 0.0000
813 DEVICE EXPULSION 3 0.0000
814 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
815 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
816 AMNESIA 3 0.0000
817 FEELING ABNORMAL 11 0.0000
818 PRODUCT PRESCRIBING ISSUE 1 0.0000
819 INFUSION RELATED REACTION 3 0.0000
820 FEBRILE NEUTROPENIA 3 0.0000
821 BLOOD PRESSURE DECREASED 3 0.0000
822 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
823 TOOTH DISORDER 1 0.0000
824 RASH MACULO-PAPULAR 1 0.0000
825 INJECTION SITE PRURITUS 3 0.0000
826 GLOSSODYNIA 1 0.0000
827 PAIN IN EXTREMITY 13 0.0000
828 HEPATIC ENZYME INCREASED 3 0.0000
829 ERYTHEMA 9 0.0000
830 MUSCLE TWITCHING 1 0.0000
831 INJURY 3 0.0000
832 PRODUCT USE ISSUE 8 0.0000
833 PRODUCT PRESCRIBING ERROR 1 0.0000
834 BLOOD PRESSURE FLUCTUATION 1 0.0000
835 FIBROMYALGIA 1 0.0000
836 PRESYNCOPE 1 0.0000
837 CEREBRAL INFARCTION 1 0.0000
838 INJECTION SITE URTICARIA 1 0.0000
839 PAIN 25 0.0000
840 ABASIA 1 0.0000
841 OSTEONECROSIS OF JAW 1 0.0000
842 DYSGEUSIA 3 0.0000
843 HEART RATE INCREASED 4 0.0000
844 EPISTAXIS 3 0.0000
845 DRY EYE 2 0.0000
846 LEUKOPENIA 2 0.0000
847 HYPOTENSION 8 0.0000
848 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
849 HAEMATEMESIS 1 0.0000
850 HEPATITIS 1 0.0000
851 HOSPITALISATION 6 0.0000
852 ERECTILE DYSFUNCTION 1 0.0000
853 UNRESPONSIVE TO STIMULI 1 0.0000
854 SKIN ULCER 1 0.0000
855 HAEMATOMA 1 0.0000
856 DIPLOPIA 1 0.0000
857 SPEECH DISORDER 2 0.0000
858 JOINT STIFFNESS 1 0.0000
859 GASTRITIS 1 0.0000
860 PANCREATITIS 2 0.0000
861 DRUG INTERACTION 6 0.0000
862 RENAL FAILURE 5 0.0000
863 DEHYDRATION 5 0.0000
864 CARDIAC FAILURE CONGESTIVE 3 0.0000
865 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
866 FEAR 1 0.0000
867 DISTURBANCE IN ATTENTION 2 0.0000
868 FREQUENT BOWEL MOVEMENTS 1 0.0000
869 THROAT TIGHTNESS 1 0.0000
870 RASH PRURITIC 2 0.0000
871 LIMB INJURY 1 0.0000
872 PNEUMONITIS 1 0.0000
873 TREATMENT NONCOMPLIANCE 2 0.0000
874 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
875 SKIN LESION 1 0.0000
876 MEMORY IMPAIRMENT 5 0.0000
877 CARDIAC ARREST 3 0.0000
878 RESPIRATORY DISTRESS 1 0.0000
879 DIVERTICULITIS 1 0.0000
880 MENTAL STATUS CHANGES 1 0.0000
881 OXYGEN SATURATION DECREASED 2 0.0000
882 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
883 ANGINA PECTORIS 1 0.0000
884 LETHARGY 2 0.0000
885 SEIZURE 4 0.0000
886 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
887 PRODUCT STORAGE ERROR 3 0.0000
888 DYSSTASIA 1 0.0000
889 DYSPHONIA 2 0.0000
890 PALPITATIONS 4 0.0000
891 LABORATORY TEST ABNORMAL 1 0.0000
892 DISEASE PROGRESSION 4 0.0000
893 URINARY INCONTINENCE 1 0.0000
894 RENAL INJURY 1 0.0000
895 BLOOD POTASSIUM DECREASED 1 0.0000
896 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
897 THERAPEUTIC RESPONSE DECREASED 2 0.0000
898 DISCOMFORT 2 0.0000
899 EPILEPSY 1 0.0000
900 DRUG ADMINISTRATION ERROR 1 0.0000
901 PERIPHERAL SWELLING 5 0.0000
902 CARDIAC DISORDER 3 0.0000
903 CYSTITIS 1 0.0000
904 MOOD SWINGS 1 0.0000
905 HYPOTHYROIDISM 1 0.0000
906 HIP FRACTURE 1 0.0000
907 HYPERHIDROSIS 4 0.0000
908 CONFUSIONAL STATE 5 0.0000
909 IMPAIRED HEALING 1 0.0000
910 EYE DISORDER 1 0.0000
911 DEATH 26 0.0000
912 VISUAL ACUITY REDUCED 1 0.0000
913 SYNCOPE 3 0.0000
914 HAEMOGLOBIN DECREASED 3 0.0000
915 HAEMATURIA 1 0.0000
916 NEOPLASM PROGRESSION 1 0.0000
917 HAEMORRHAGE 3 0.0000
918 RASH MACULAR 1 0.0000
919 DRUG EFFECT INCOMPLETE 1 0.0000
920 CRYING 1 0.0000
921 UNDERDOSE 2 0.0000
922 MALAISE 12 0.0000
923 INJECTION SITE MASS 1 0.0000
924 HYPOAESTHESIA 4 0.0000
925 DYSARTHRIA 1 0.0000
926 BLOOD PRESSURE INCREASED 4 0.0000
927 ACUTE KIDNEY INJURY 4 0.0000
928 PLASMA CELL MYELOMA 1 0.0000
929 CHILLS 3 0.0000
930 EMOTIONAL DISTRESS 3 0.0000
931 DEVICE BREAKAGE 1 0.0000
932 NEUTROPHIL COUNT DECREASED 1 0.0000
933 ROAD TRAFFIC ACCIDENT 1 0.0000
934 URTICARIA 4 0.0000
935 WITHDRAWAL SYNDROME 1 0.0000
936 RENAL IMPAIRMENT 2 0.0000
937 SKIN EXFOLIATION 2 0.0000
938 MYALGIA 4 0.0000
939 VAGINAL HAEMORRHAGE 1 0.0000
940 DEVICE DISLOCATION 1 0.0000
941 INJECTION SITE PAIN 7 0.0000
942 DRUG INEFFECTIVE 30 0.0000
943 COLITIS ULCERATIVE 1 0.0000
944 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
945 DEVICE ISSUE 2 0.0000
946 VISION BLURRED 3 0.0000
947 ADVERSE EVENT 2 0.0000
948 COGNITIVE DISORDER 1 0.0000
949 RASH ERYTHEMATOUS 1 0.0000
950 BLOOD GLUCOSE DECREASED 1 0.0000
951 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
952 HYPOGLYCAEMIA 1 0.0000
953 AGGRESSION 1 0.0000
954 CELLULITIS 1 0.0000
955 FLUID RETENTION 1 0.0000
956 INFLAMMATION 1 0.0000
957 PLATELET COUNT DECREASED 2 0.0000
958 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
959 ARTHROPATHY 1 0.0000
960 BONE PAIN 1 0.0000
961 BLADDER CANCER 1 0.0000
962 STOMATITIS 1 0.0000
963 ILL-DEFINED DISORDER 1 0.0000
964 FEELING HOT 1 0.0000
965 SWELLING FACE 1 0.0000
966 DEVICE DIFFICULT TO USE 1 0.0000
967 INJECTION SITE REACTION 1 0.0000
968 BURNING SENSATION 1 0.0000
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
970 THERAPY INTERRUPTED 1 0.0000
971 MOBILITY DECREASED 1 0.0000
972 OVERDOSE 3 0.0000
973 RESPIRATORY FAILURE 1 0.0000
974 ACNE 1 0.0000
975 INCORRECT DOSE ADMINISTERED 3 0.0000
976 CARDIAC FAILURE 1 0.0000
977 INFLUENZA LIKE ILLNESS 1 0.0000
978 DRUG ABUSE 1 0.0000
979 CEREBROVASCULAR ACCIDENT 2 0.0000
980 TACHYCARDIA 1 0.0000
981 NO ADVERSE EVENT 2 0.0000
982 BREAST CANCER 1 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
985 INJECTION SITE ERYTHEMA 1 0.0000
986 BLOOD GLUCOSE INCREASED 1 0.0000